In contrast, a study investigating whether STKIs—including dasatinib—exerted their inhibitory effect on HIV-1 infection through the interaction between c-SRC and its ligand PTK2B concluded that multiple postentry steps played a major role in blocking HIV-1 infection (McCarthy et al., 2016). Here, PTK2B is linked to HIV-1 infection.